SEARCH

SEARCH BY CITATION

References

  • 1
    Jochmans D ( 2008) Novel HIV-1 reverse transcriptase inhibitors. Virus Res 134: 171185.
  • 2
    Ren J, Stammers DK ( 2005) HIV reverse transcriptase structures: designing new inhibitors and understanding mechanisms of drug resistance. Trends Pharmacol Sci 26: 47.
  • 3
    Dieterich DT ( 2003) Long-term complications of nucleoside reverse transcriptase inhibitor therapy. AIDS Read 13: 17684, 187.
  • 4
    Nolan D, Mallal S ( 2004) Complications associated with NRTI therapy: update on clinical features and possible pathogenic mechanisms. Antivir Ther 9: 849863.
  • 5
    Shafer RW, Rhee SY, Pillay D, Miller V, Sandstrom P, Schapiro JM, Kuritzkes DR, Bennett D ( 2007) HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS 21: 215223.
  • 6
    Geretti AM ( 2006) Clinical implications of HIV drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors. AIDS Rev 8: 210220.
  • 7
    Bartlett JA, Fath MJ, Demasi R, Hermes A, Quinn J, Mondou E, Rousseau F ( 2006) An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults. AIDS 20: 20512064.
  • 8
    Pal D, Mitra AK ( 2006) MDR- and CYP3A4-mediated drug-drug interactions. J Neuroimmune Pharmacol 1: 323339.
  • 9
    Kliewer SA, Goodwin B, Willson TM ( 2002) The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 23: 687702.
  • 10
    Carnahan VE, Redinbo MR ( 2005) Structure and function of the human nuclear xenobiotic receptor PXR. Curr Drug Metab 6: 357367.
  • 11
    Teotico DG, Bischof JJ, Peng L, Kliewer SA, Redinbo MR ( 2008) Structural basis of human pregnane X receptor activation by the hops constituent colupulone. Mol Pharmacol 74: 15121520.
  • 12
    Xue Y, Moore LB, Orans J, Peng L, Bencharit S, Kliewer SA, Redinbo MR ( 2007) Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition. Mol Endocrinol 21: 10281038.
  • 13
    Xue Y, Chao E, Zuercher WJ, Willson TM, Collins JL, Redinbo MR ( 2007) Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism. Bioorg Med Chem 15: 21562166.
  • 14
    Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM, Davis-Searles PR, Lambert MH, Kliewer SA, Redinbo MR ( 2003) 2.1 Å crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry 42: 14301438.
  • 15
    Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR ( 2001) The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292: 23292333.
  • 16
    Chrencik JE, Orans J, Moore LB, Xue Y, Peng L, Collins JL, Wisely GB, Lambert MH, Kliewer SA, Redinbo MR ( 2005) Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin. Mol Endocrinol 19: 11251134.
  • 17
    Watkins RE, Davis-Searles PR, Lambert MH, Redinbo MR ( 2003) Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J Mol Biol 331: 815828.
  • 18
    Campiani G, Ramunno A, Maga G, Nacci V, Fattorusso C, Catalanotti B, Morelli E, Novellino E ( 2002) Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives. Curr Pharm Des 8: 615657.
  • 19
    Ekins S, Kortagere S, Iyer M, Reschly EJ, Lill MA, Redinbo MR, Krasowski MD ( 2009) Challenges predicting ligand-receptor interactions of promiscuous proteins: the nuclear receptor PXR. PLoS Comput Biol 5: e1000594.
  • 20
    Ngan CH, Beglov D, Rudnitskaya AN, Kozakov D, Waxman DJ, Vajda S, ( 2009) The structural basis of pregnane X receptor binding promiscuity. Biochemistry 48: 1157211581.
  • 21
    Otwinowski Z, Minor W ( 1997) Methods in Enzymology: Macromolecular Crystallography, part A. Processing of x-ray diffraction data collected in oscillation mode. In: Carter CWJ, Sweet RM, Eds. New York: Academic Press. 276: 307326.
  • 22
    Murshudov GN, Vagin AA, Dodson EJ ( 1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53: 240255.
  • 23
    Collaborative Computational Project, Number 4 ( 1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760763.
  • 24
    Emsley P, Cowtan K ( 2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 21262132.
  • 25
    Winn MD, Murshudov GN, Papiz MZ ( 2003) Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol 374: 300321.
  • 26
    Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. ( 1998) Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54: 905921.
  • 27
    Delano WL ( 2002) The PyMOL molecular graphics system. San Carlos, CA: DeLano Scientific LLC.